{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T10:40:20Z","timestamp":1688467220253},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0074027","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T21:03:06Z","timestamp":1378414986000},"page":"e74027","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sensitivity of a Ribavirin Resistant Mutant of Hepatitis C Virus to Other Antiviral Drugs"],"prefix":"10.1371","volume":"8","author":[{"given":"Kathleen B.","family":"Mihalik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino A.","family":"Feigelstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"key":"ref1","unstructured":"Lindenbach BD, Thimme R, Rice CM (2007) Flaviviridae: the viruses and their replication. Lippincott-Raven Publishers, Philadelphia, PA 1101\u20131152."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","article-title":"Hepatitis-C Virus-Infection Is Associated with the Development of Hepatocellular-Carcinoma","volume":"87","author":"I Saito","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref3","unstructured":"Alter H, Seeff LB (1997) Zuckermanm AZ, Thomas HC, editors. Viral Hepatitis. Edinburgh: Churchill Livingstone. 467\u2013498."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1056\/NEJMoa1014463","article-title":"Response-guided telaprevir combination treatment for hepatitis C virus infection","volume":"365","author":"KE Sherman","year":"2011","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJMc1105515","article-title":"Boceprevir for chronic HCV genotype 1 infection","volume":"365","author":"AR Limaye","year":"2011","journal-title":"N Engl J Med"},{"key":"ref7","first-page":"749","article-title":"The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis C. Hepatology","volume":"55","author":"S Zeuzem","year":"2012"},{"key":"ref8","first-page":"S0016","article-title":"Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infection","volume":"2047\u20132055","author":"S Zeuzem","year":"2011","journal-title":"Gastroenterology 141"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22070","article-title":"Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop","volume":"47","author":"RT Chung","year":"2008","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2010.03.037","article-title":"Ribavirin improves early responses to peginterferon through improved interferon signaling","volume":"139","author":"JJ Feld","year":"2010","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref12","first-page":"1743","article-title":"Selection of hepatitis C virus resistant to ribavirin","volume":"402","author":"DA Feigelstock","year":"2011","journal-title":"Virol J 8"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1743-422X-7-44","article-title":"Increased susceptibility of Huh7 cells to HCV replication does not require mutations in RIG-I","volume":"7","author":"DA Feigelstock","year":"2010","journal-title":"Virol J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1634\/theoncologist.7-4-288","article-title":"Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review","volume":"7","author":"M Malet-Martino","year":"2002","journal-title":"Oncologist"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00535-007-2099-8","article-title":"Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil\/interferon combination therapy in patients with advanced hepatocellular carcinoma","volume":"42","author":"K Uka","year":"2007","journal-title":"J Gastroenterol"},{"key":"ref16","first-page":"PONE","article-title":"Mutagenesis-mediated virus extinction: virus-dependent effect of viral load on sensitivity to lethal defection","volume":"e32550","author":"H Moreno","year":"2012","journal-title":"PLoS One 7"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"S Crotty","year":"2000","journal-title":"Nat Med"},{"key":"ref18","first-page":"JVI.05712","article-title":"Mutational robustness of an RNA virus influences sensitivity to lethal mutagenesis","volume":"2869\u20132873","author":"JD Graci","year":"2012","journal-title":"J Virol 86"},{"key":"ref19","first-page":"S0042682203001442","article-title":"Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis","volume":"339\u2013349","author":"A Airaksinen","year":"2003","journal-title":"Virology 311"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Day CW, Smee DF, Julander JG, Yamshchikov VF, Sidwell RW, <etal>et al<\/etal>.. (2005) Error-prone replication of West Nile virus caused by ribavirin. Antiviral Res 67: 38\u201345. S0166\u20133542(05)00077-X; doi:10.1016\/j.antiviral.2005.04.002.","DOI":"10.1016\/j.antiviral.2005.04.002"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"8074","DOI":"10.1128\/JVI.75.17.8074-8081.2001","article-title":"Ribavirin induces error-prone replication of GB virus B in primary tamarin hepatocytes","volume":"75","author":"RE Lanford","year":"2001","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1128\/JVI.77.1.481-488.2003","article-title":"Ribavirin causes error catastrophe during Hantaan virus replication","volume":"77","author":"WE Severson","year":"2003","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1177\/135965350701200505","article-title":"Effect of ribavirin on the hepatitis C virus (JFH-1) and its correlation with interferon sensitivity","volume":"12","author":"E Brochot","year":"2007","journal-title":"Antivir Ther"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8505","DOI":"10.1128\/JVI.76.17.8505-8517.2002","article-title":"Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system","volume":"76","author":"AM Contreras","year":"2002","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1053\/j.gastro.2006.12.005","article-title":"Mutagenic effect of ribavirin on hepatitis C nonstructural 5B quasispecies in vitro and during antiviral therapy","volume":"132","author":"WP Hofmann","year":"2007","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2893.2004.00531.x","article-title":"Inhibition of subgenomic hepatitis C virus RNA in Huh-7 cells: ribavirin induces mutagenesis in HCV RNA","volume":"11","author":"T Kanda","year":"2004","journal-title":"J Viral Hepat"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1053\/j.gastro.2007.03.035","article-title":"Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy","volume":"132","author":"G Lutchman","year":"2007","journal-title":"Gastroenterology"},{"key":"ref28","first-page":"JVI.02778","article-title":"Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients","volume":"6172\u20136181","author":"J Dietz","year":"2013","journal-title":"J Virol 87"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1081\/NCN-200060112","article-title":"Nm 283, an efficient prodrug of the potent anti-HCV agent 2\u2032-C-methylcytidine","volume":"24","author":"C Pierra","year":"2005","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/jm0603623","article-title":"Synthesis and pharmacokinetics of valopicitabine (NM283), an efficient prodrug of the potent anti-HCV agent 2\u2032-C-methylcytidine","volume":"49","author":"C Pierra","year":"2006","journal-title":"J Med Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.coph.2008.09.007","article-title":"Recent progress in the development of selected hepatitis C virus NS3.4A protease and NS5B polymerase inhibitors","volume":"8","author":"AD Kwong","year":"2008","journal-title":"Current Opinion in Pharmacology"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Godofsky E, Afdahl N, Rustgi V, Schick L, Duncan L, <etal>et al<\/etal>.. (2004) First clinical results for a novel antiviral treatment for hepatitis C: a phase I\/III dose escalation trial assessing tolerance, pharmacokinetics and antiviral activity on NM283, a novel antiviral treatment for hepaititis C. Gastroenterology.","DOI":"10.1016\/S0168-8278(04)90096-7"},{"key":"ref33","first-page":"726A","article-title":"Final phase I\/II trial results for NM283, a new polymerease inhibitor for hepatitits C: antiviral efficacy and tolerance in patients with HCV-1 infection, including revious interferon failures","volume":"2004","author":"N Afdahl","year":"2004","journal-title":"55th AnnualMeeting of the American Association for the Study of LiverDiseases October 29-November 2; Boston, Massachusetts"},{"key":"ref34","unstructured":"Reddy R, Rodriguez-Torres M, Gane E, Robson R, Lalezar J, <etal>et al<\/etal>.. (2007) Antiviral activity, pharmacokinetics, safety, and tolerability of R7128, a novel nucleoside HCV RNA polymerase inhibitor, following multiple, ascending, oral doses in patients with HCV Genotype 1 infection who have failed prior interferon therapy. 58th Annual Meeting of the American Association for the Study ofLiver Diseases (AASLD) November 2\u20136; Boston, MA, USA: 2007."},{"key":"ref35","first-page":"AAC.01152","article-title":"Antiviral efficacy upon administration of a HepDirect prodrug of 2\u2032-C-methylcytidine to hepatitis C virus-infected chimpanzees","volume":"3854\u20133860","author":"SS Carroll","year":"2011","journal-title":"Antimicrob Agents Chemother 55"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.virol.2006.03.045","article-title":"In vitro selected Con1 subgenomic replicons resistant to 2\u2032-C-methyl-cytidine or to R1479 show lack of cross resistance","volume":"351","author":"S Le Pogam","year":"2006","journal-title":"Virology"},{"key":"ref37","first-page":"50\/10\/3444","article-title":"Ribavirin antagonizes the in vitro anti-hepatitis C virus activity of 2\u2032-C-methylcytidine, the active component of valopicitabine","volume":"3444\u20133446","author":"L Coelmont","year":"2006","journal-title":"Antimicrob Agents Chemother 50"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"46094","DOI":"10.1074\/jbc.C100349200","article-title":"Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin","volume":"276","author":"D Maag","year":"2001","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1021\/bi0344681","article-title":"Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase","volume":"42","author":"NV Vo","year":"2003","journal-title":"Biochemistry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1128\/JVI.01606-06","article-title":"Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe","volume":"81","author":"M Sierra","year":"2007","journal-title":"J Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e5554","DOI":"10.1371\/journal.pone.0005554","article-title":"Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment","volume":"4","author":"C Perales","year":"2009","journal-title":"PLoS One"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/13305","article-title":"Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site","volume":"6","author":"CA Lesburg","year":"1999","journal-title":"Nature Structural Biology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"18202","DOI":"10.1074\/jbc.M413410200","article-title":"Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors","volume":"280","author":"BK Biswal","year":"2005","journal-title":"J Biol Chem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.1073\/pnas.1232294100","article-title":"A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity","volume":"100","author":"JK Pfeiffer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"M Vignuzzi","year":"2006","journal-title":"Nature"},{"key":"ref46","first-page":"M407787200","article-title":"The NS5A protein of hepatitis C virus is a zinc metalloprotein","author":"TL Tellinghuisen","year":"2004","journal-title":"J Biol Chem 279"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1128\/JVI.77.9.5487-5492.2003","article-title":"Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons","volume":"77","author":"R Gosert","year":"2003","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1128\/JVI.78.14.7400-7409.2004","article-title":"Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes","volume":"78","author":"D Moradpour","year":"2004","journal-title":"J Virol"},{"key":"ref49","first-page":"85\/9\/2485","article-title":"Hepatitis C virus NS5A: tales of a promiscuous protein","volume":"2485\u20132502","author":"A Macdonald","year":"2004","journal-title":"J Gen Virol 85"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI118025","article-title":"Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region","volume":"96","author":"N Enomoto","year":"1995","journal-title":"J Clin Invest"},{"key":"ref51","first-page":"763","article-title":"Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system","volume":"17","author":"HH Hsu","year":"1993","journal-title":"Hepatology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0074027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T10:27:32Z","timestamp":1688466452000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0074027"}},"subtitle":[],"editor":[{"given":"Hak","family":"Hotta","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":51,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,9,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0074027","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}